Aligning Medications With What Matters Most

NACompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

May 2, 2022

Study Completion Date

May 2, 2022

Conditions
PolypharmacyAlzheimer Disease and Related Dementias
Interventions
BEHAVIORAL

Pharmacist-led deprescribing intervention

1\) direct-to-consumer deprescribing educational materials designed to activate the care partner and people living with dementia PLWD; 2) a telehealth visit in which a clinical pharmacist discusses benefits and harms of the patient's medications with the patient and care partner in the context of their goals and preferences; and 3) pharmacist-PCP communication in which the pharmacist provides tailored deprescribing recommendations designed to be useful and actionable for the PCP

Trial Locations (2)

21224

Johns Hopkins Bayview Medical Center, Baltimore

80014

Kaiser Permanente, Aurora

All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Johns Hopkins University

OTHER